Correction: Obesity drug story

AP News
|
Posted: Dec 28, 2009 5:58 AM

In a Dec. 22 story about obesity drugs, The Associated Press erroneously reported when Orexigen Therapeutics Inc. plans to file for approval of its drug candidate Contrave32. It plans to file in the first half of 2010, not by the end of the year.